Human growth hormone (HGH) peptide therapy can help you handle disruptive symptoms caused by aging or injury
eine Zulassung fr die klinische Therapie liegt noch nicht vor
Lamin A, farnesylation and aging
Chemical Makeup (3)(4)(5) Molecular formula: CJC-1295 (Mod GRF 1-29) : C 152 H 252 N 44 O 42 Ipamorelin : C 38 H 49 N 9 O 5 GHRP-2: C 45 H 55 N 9 O 6 Molecular weight: CJC-1295 (Mod GRF 1-29) : 3367.9 g/mol Ipamorelin : 711.9 g/mol GHRP-2 : 817.9 g/mol Other known titles: Ipamorelin Ipamorelin Acetate, IPA GHRP-2 Pralmorelin, Growth hormone-releasing peptide-2 Research and Clinical Studies CJC-1295 (Mod GRF 1-29), Ipamorelin, GHRP-2 Blend and Growth Hormone Deficiencies Numerous clinical studies have been conducted on test subjects exhibiting growth hormone deficiency
Summary Ipamorelin is the cleaner, more selective GH research tool producing equivalent GH release with substantially less cortisol, prolactin, and appetite stimulation
Typical Cycle Length Minimum: 8 weeks Typical: 1216 weeks Long-term (anti-aging): Continuous with intermittent breaks Ipamorelin does not cause shutdown of natural GH production, making it suitable for long-term use without PCT
